Weight and Metabolic Health Review: Specialist in Dubai
Weight, blood sugar, blood pressure, triglycerides and fatty liver travel together, and treating them together works better than treating each result on its own. A metabolic review looks at the whole set, finds where you are, and sets a plan that uses what the evidence supports, including supervised medication where it is appropriate. At Smart Care Polyclinic in Deira it is led by the internal medicine specialist who also runs the medical weight-management programme.
For: weight that will not shift, prediabetes, fatty liver, high triglycerides, central weight
Takes: a 30-minute consultation; metabolic bloods on site
Price: consultation AED 125, waived when a programme is booked
Book the internal medicine specialistor call +971 (0) 4379 3562
What it is
The review measures what matters: weight, waist, blood pressure, HbA1c and fasting glucose, lipids with triglycerides, liver enzymes, thyroid, and, where indicated, insulin and vitamin D. Together they show whether insulin resistance is present and how far it has progressed towards diabetes and fatty liver, which is the information that motivates change and directs treatment.
The plan is built on the evidence, including its limits. Structured diet and activity change is the foundation and works for many. For others, medication under supervision changes the odds substantially: in the STEP 5 trial, adults on semaglutide sustained an average weight loss of around 15% over two years, an average with wide individual variation.1 And when the medication stops, most of the weight returns over the following year, as the STEP 1 extension showed, which is why the programme is planned as a treatment with maintenance rather than a course with an end.2
Who the programme suits
People with a body mass index in the obesity range, or overweight with a weight-related condition such as prediabetes, fatty liver, high blood pressure or sleep apnoea, who have made a real attempt with diet and activity. The specialist assesses suitability, the contraindications, and the alternatives, and the programme page states the price and what the trials found.
What is not offered
Medication without assessment, medication for people who do not meet the criteria, and any promise of a number. The results quoted are averages from trials; individual results vary widely either side, and the consultation says so.
The consultation, and what follows from it
Internal medicine consultation
Assessment, examination and a plan with every cost stated before anything further is done.
AED 125 was AED 200
Bookthe programme, the evidence, the price
the metabolic panel, read by the specialist
Questions patients ask
A cluster of central weight, raised blood pressure, raised triglycerides, low HDL and raised blood sugar that together sharply increase the risk of diabetes and heart disease. Treating the cluster, starting with weight, improves all of them.
In the trials, yes, on average substantially, over the period the medication is taken; weight largely returns when it stops. They are prescribed here after assessment, within a supervised programme, for people who meet the criteria.
The weight-management consultation fee is waived when a programme is booked. The programme page sets out what is included.
This guide is general information, not advice about you. Long-term conditions are managed on your own results and history, which is what the specialist consultation is for.
References
- Garvey WT, Batterham RL, Bhatta M, et al.. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10):2083-2091. PMID 36216945. doi:10.1038/s41591-022-02026-4Average weight loss sustained over two years in a randomised trial — an average, with individual results ranging widely either side of it.
- Wilding JPH, Batterham RL, Davies M, et al.. Weight regain and cardiometabolic effects after withdrawal of semaglutide: The STEP 1 trial extension. Diabetes, Obesity and Metabolism. 2022;24(8):1553-1564. PMID 35441470. doi:10.1111/dom.14725Weight and cardiometabolic measures largely returned towards baseline a year after the medication stopped — cited so nobody reads a weight programme as a one-off fix.
Sources are listed for the specific statements they support. They are published research and guidance, not a substitute for a consultation — what applies to you is decided by a doctor who has assessed you.